These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 12534776)

  • 21. Hepatitis B vaccine effectiveness in the face of global HBV genotype diversity.
    Cassidy A; Mossman S; Olivieri A; De Ridder M; Leroux-Roels G
    Expert Rev Vaccines; 2011 Dec; 10(12):1709-15. PubMed ID: 22085174
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Last Ten Years of Advancements in Plant-Derived Recombinant Vaccines against Hepatitis B.
    Joung YH; Park SH; Moon KB; Jeon JH; Cho HS; Kim HS
    Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27754367
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of an Allergy Immunotherapy Leads to a New Type of Hepatitis B Vaccine.
    Gerlich WH; Glebe D
    EBioMedicine; 2016 Sep; 11():5-6. PubMed ID: 27485030
    [No Abstract]   [Full Text] [Related]  

  • 24. Seroconversion rate after postnatal immunoprophylaxis for exposed infants in prevention of hepatitis B vertical transmission.
    Ramanan PV; Premkumar S; Khanna P; Sahni L
    J Trop Pediatr; 2011 Oct; 57(5):399. PubMed ID: 21212130
    [No Abstract]   [Full Text] [Related]  

  • 25. Hepatitis B virus (HBV) infection and multiple sclerosis: One more reason to undergo vaccination?
    Mormile R
    Immunol Lett; 2015 May; 165(1):60-1. PubMed ID: 25794632
    [No Abstract]   [Full Text] [Related]  

  • 26. Hepatitis B virus therapy: What's the future holding for us?
    Manzoor S; Saalim M; Imran M; Resham S; Ashraf J
    World J Gastroenterol; 2015 Nov; 21(44):12558-75. PubMed ID: 26640332
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factors influencing immunologic response to hepatitis B vaccine in adults.
    Yang S; Tian G; Cui Y; Ding C; Deng M; Yu C; Xu K; Ren J; Yao J; Li Y; Cao Q; Chen P; Xie T; Wang C; Wang B; Mao C; Ruan B; Jiang T; Li L
    Sci Rep; 2016 Jun; 6():27251. PubMed ID: 27324884
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Short-term immunogenicity of standard and accelerated hepatitis B virus vaccination schedules in healthy adults: a comparative field study in China.
    Zhang X; Wang J; Chen X; Yu M; Yu S; Sun Y; Duan J; Sun H; Yuan P
    Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30201691
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transplacental passage of hepatitis B virus DNA from hepatitis B e antigen-negative mothers and delayed immune response in newborns.
    Badur S; Lazizi Y; Ugurlu M; Perk Y; Ilter O; Aydinli K; Pillot J
    J Infect Dis; 1994 Mar; 169(3):704-6. PubMed ID: 8158060
    [No Abstract]   [Full Text] [Related]  

  • 30. [Immunization and problems of newborns receiving hepatitis B vaccines in countryside].
    Li RC
    Zhonghua Gan Zang Bing Za Zhi; 2003 Apr; 11(4):241. PubMed ID: 12716529
    [No Abstract]   [Full Text] [Related]  

  • 31. Immune balance in Hepatitis B Infection: Present and Future Therapies.
    Vyas AK; Jindal A; Hissar S; Ramakrishna G; Trehanpati N
    Scand J Immunol; 2017 Jul; 86(1):4-14. PubMed ID: 28387980
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatitis B vaccine: extending immunogenicity.
    Horton RC
    Br J Hosp Med; 1990 Jun; 43(6):409. PubMed ID: 2364233
    [No Abstract]   [Full Text] [Related]  

  • 33. [Clinical and therapeutic significance of hepatitis B virus heterogeneity].
    Campos RH; López JL
    Rev Clin Esp; 2001 Dec; 201(12):713-4. PubMed ID: 11835884
    [No Abstract]   [Full Text] [Related]  

  • 34. Prophylaxis against hepatitis B reactivation among patients with lymphoma receiving rituximab.
    Buensalido JA; Chandrasekar PH
    Expert Rev Anti Infect Ther; 2014 Feb; 12(2):151-4. PubMed ID: 24341369
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of thymopentin in hemodialyzed hepatitis B vaccine non-responders.
    Peralta S; Ribisi La Spina AM; Genovese G; La Iuppa M; Rotolo G; Tumbiolo S; Rini GB; Colimberti D
    J Chemother; 1989 Jul; 1(4 Suppl):1084-5. PubMed ID: 16312782
    [No Abstract]   [Full Text] [Related]  

  • 36. Non-responders to hepatitis B vaccination: a review.
    Kubba AK; Taylor P; Graneek B; Strobel S
    Commun Dis Public Health; 2003 Jun; 6(2):106-12. PubMed ID: 12889288
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A two-dose hepatitis B vaccine for adults (Heplisav-B).
    Med Lett Drugs Ther; 2018 Jan; 60(1539):17-18. PubMed ID: 29364196
    [No Abstract]   [Full Text] [Related]  

  • 38. Possible benefits of the targeting of indoleamine 2,3-dioxygenase (IDO) in hepatitis B vaccination.
    Straten PT; Andersen MH
    Vaccine; 2011 May; 29(21):3728. PubMed ID: 21420415
    [No Abstract]   [Full Text] [Related]  

  • 39. Strategies for global prevention of hepatitis B virus infection.
    Van Damme P; Zanetti AR; Shouval D; Van Herck K
    Adv Exp Med Biol; 2010; 659():175-88. PubMed ID: 20204764
    [No Abstract]   [Full Text] [Related]  

  • 40. Evaluation of new approaches to prophylactic and therapeutic vaccinations against hepatitis B viruses in the woodchuck model.
    Lu M; Roggendorf M
    Intervirology; 2001; 44(2-3):124-31. PubMed ID: 11509873
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.